Financials BioHarvest Sciences Inc. Canadian Securities Exchange
Equities
BHSC
CA13767B1013
Food Processing
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 CAD | +6.06% | -2.94% | +46.67% |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Capitalization 1 | 78.51 | 165 | 98.54 | 77.63 |
Enterprise Value (EV) 1 | 79.44 | 163.6 | 107.4 | 94.62 |
P/E ratio | -9.12 x | -16.1 x | -8.7 x | -6.11 x |
Yield | - | - | - | - |
Capitalization / Revenue | 198 x | 78.5 x | 17.9 x | 6.13 x |
EV / Revenue | 201 x | 77.8 x | 19.5 x | 7.47 x |
EV / EBITDA | -14.4 x | -19.4 x | -10.4 x | -9.88 x |
EV / FCF | -22 x | -42.8 x | -15.2 x | -18.6 x |
FCF Yield | -4.54% | -2.34% | -6.6% | -5.36% |
Price to Book | -31.6 x | 57.8 x | -16.6 x | -5.23 x |
Nbr of stocks (in thousands) | 444,455 | 453,630 | 460,716 | 478,688 |
Reference price 2 | 0.1766 | 0.3638 | 0.2139 | 0.1622 |
Announcement Date | 4/29/21 | 4/28/22 | 4/27/23 | 4/30/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 0.449 | 0.218 | 0.396 | 2.102 | 5.498 | 12.67 |
EBITDA 1 | -2.515 | -2.247 | -5.519 | -8.426 | -10.33 | -9.576 |
EBIT 1 | -2.585 | -2.31 | -5.567 | -8.491 | -10.61 | -9.966 |
Operating Margin | -575.72% | -1,059.63% | -1,405.81% | -403.95% | -193.02% | -78.65% |
Earnings before Tax (EBT) 1 | -7.472 | -5.31 | -6.584 | -9.827 | -11.24 | -12.56 |
Net income 1 | -6.673 | -4.27 | -6.584 | -9.827 | -11.24 | -12.56 |
Net margin | -1,486.19% | -1,958.72% | -1,662.63% | -467.51% | -204.37% | -99.15% |
EPS 2 | -0.7075 | -0.3400 | -0.0194 | -0.0226 | -0.0246 | -0.0265 |
Free Cash Flow 1 | 0.1132 | -2.076 | -3.604 | -3.826 | -7.086 | -5.076 |
FCF margin | 25.22% | -952.24% | -910.04% | -182.02% | -128.88% | -40.05% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/21/20 | 4/29/20 | 4/29/21 | 4/28/22 | 4/27/23 | 4/30/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 18.1 | 23.1 | 0.93 | - | 8.82 | 17 |
Net Cash position 1 | - | - | - | 1.46 | - | - |
Leverage (Debt/EBITDA) | -7.183 x | -10.29 x | -0.1689 x | - | -0.8543 x | -1.774 x |
Free Cash Flow 1 | 0.11 | -2.08 | -3.6 | -3.83 | -7.09 | -5.08 |
ROE (net income / shareholders' equity) | 35.3% | 21.4% | 45% | -3,510% | 731% | 121% |
ROA (Net income/ Total Assets) | -90.1% | -73.7% | -95% | -68.4% | -67.7% | -51.1% |
Assets 1 | 7.41 | 5.791 | 6.931 | 14.36 | 16.6 | 24.6 |
Book Value Per Share 2 | -2.790 | -3.240 | -0.0100 | 0.0100 | -0.0100 | -0.0300 |
Cash Flow per Share 2 | 0.1300 | 0.1000 | 0 | 0.0100 | 0 | 0.0100 |
Capex 1 | 0.05 | 0.03 | 0.17 | 1.64 | 1.26 | 1.47 |
Capex / Sales | 11.8% | 15.6% | 43.69% | 78.02% | 22.84% | 11.63% |
Announcement Date | 4/21/20 | 4/29/20 | 4/29/21 | 4/28/22 | 4/27/23 | 4/30/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+15.21% | 8.29B | |
+5.29% | 7.61B | |
+0.73% | 5.96B | |
-7.30% | 3.72B | |
-9.63% | 3.61B | |
-5.76% | 1.3B | |
-28.60% | 1.07B | |
+15.23% | 994M | |
-12.84% | 890M |
- Stock Market
- Equities
- BHSC Stock
- BHSC Stock
- Financials BioHarvest Sciences Inc.